SOLUTION PHARMACEUTIQUE D'ADRÉNALINE POUR DISPOSITIF D'INJECTION

European patent · EP3955893 · In force

Register entry

Publication number
EP3955893
Application number
EP20720393
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 15, 2020
Published
Feb 23, 2022
Granted
Jun 7, 2023
Protection ends at the latest
Apr 14, 2040
Next annual fee due
Apr 30, 2027
IPC classes
A61K 9/08 (2006.01)
A61K 47/10 (2017.01)
A61K 47/18 (2017.01)
A61K 31/137 (2006.01)
A61P 9/04 (2006.01)
Priority
FR 1904166 18.04.2019
PCT application
PCT/EP2020/060523 15.04.2020
PCT publication
WO2020/212381 22.10.2020
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  5. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  6. Jun 15, 2023

    Agent entered

    Representative
    GERMAIN ET MAUREAU, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 15.06.2023

  7. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Holder

CROSSJECT

Crossject

6 rue Pauline Kergomard ZAC Parc Mazen Sully, 21000 Dijon, FR

Agent

GERMAIN ET MAUREAU

1204 Genève

Inventor

RESSEJEAC, Audrey

21850 SAINT APOLLINAIRE, FR

TEILLAUD, Eric

21121 DAIX, FR

BAUMARD, Nicolas

21000 DIJON, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.